Detalles de la búsqueda
1.
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer.
Cancer Sci
; 115(5): 1656-1664, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38450844
2.
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer.
Oncologist
; 29(5): e681-e689, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241181
3.
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.
Cancer Immunol Immunother
; 72(6): 1699-1707, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617602
4.
Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer.
Support Care Cancer
; 31(5): 308, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37115357
5.
Combinatorial expression of claudins in the proximal renal tubule and its functional consequences.
Am J Physiol Renal Physiol
; 318(5): F1138-F1146, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32174144
6.
Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease.
Rheumatology (Oxford)
; 2019 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851107
7.
Regulation of Epithelial Cell Functions by the Osmolality and Hydrostatic Pressure Gradients: A Possible Role of the Tight Junction as a Sensor.
Int J Mol Sci
; 20(14)2019 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319610
8.
Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
Respir Res
; 19(1): 162, 2018 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30165854
9.
Analysis of the 'angulin' proteins LSR, ILDR1 and ILDR2--tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis.
J Cell Sci
; 126(Pt 4): 966-77, 2013 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23239027
10.
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.
Mol Cancer Ther
; 23(2): 212-222, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802502
11.
Efficacy and Safety of Docetaxel plus Ramucirumab for Patients with Pretreated Advanced or Recurrent Non-small Cell Lung Cancer: Focus on Older Patients.
Target Oncol
; 19(3): 411-421, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467958
12.
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.
Cancer Lett
; 587: 216692, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342232
13.
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
Front Immunol
; 15: 1348034, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38464519
14.
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study.
JTO Clin Res Rep
; 5(3): 100644, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444594
15.
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case report.
Respirol Case Rep
; 11(9): e01208, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614813
16.
Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study).
Ther Adv Med Oncol
; 15: 17588359231177022, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333903
17.
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.
Case Rep Oncol
; 16(1): 771-778, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37900825
18.
Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study.
Target Oncol
; 18(5): 657-665, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37610516
19.
Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors.
JTO Clin Res Rep
; 4(6): 100525, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37426308
20.
Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study.
JTO Clin Res Rep
; 4(4): 100493, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37025120